An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population

Author:

Martínez-Sanz Javier12ORCID,Vivancos-Gallego María Jesús12,Fernández-Felix Borja Manuel34,Muriel Alfonso345,Pérez-Elías Pilar6,Uranga Almudena6,Romero Beatriz47,Galán Juan Carlos47,Moreno Santiago125,Pérez-Elías María Jesús12

Affiliation:

1. Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain

2. CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

3. Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain

4. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

5. Universidad de Alcalá, Madrid, Spain

6. Centro de Salud García Noblejas, Madrid, Spain

7. Department of Microbiology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain

Abstract

Despite the highly effective treatments currently available, HCV remains one of the major public health problems related to an infectious agent, mainly because a high percentage of individuals remain undiagnosed. Universal screening has been proposed as a way to end this epidemic; however, it is not feasible in all settings due to different implementation barriers.

Funder

MEC | Instituto de Salud Carlos III

Ministerio de Sanidad, Servicios Sociales e Igualdad

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference20 articles.

1. European Centre for Disease Prevention and Control. 2021. Hepatitis B and C testing in the EU/EEA: progress in reaching the elimination targets. European Centre for Disease Prevention and Control, Stockholm, Sweden. https://www.ecdc.europa.eu/sites/default/files/documents/Hepatitis-B-and%20C-Testing-in-the-EU-EEA-and-UK.pdf.

2. European Centre for Disease Prevention and Control. 2021. Hepatitis C: annual epidemiological report for 2019. European Centre for Disease Prevention and Control, Stockholm, Sweden. https://www.ecdc.europa.eu/sites/default/files/documents/AER-Hepatitis-C-2019.pdf.

3. European Centre for Disease Prevention and Control. 2016. Systematic review on hepatitis B and C prevalence in the EU/EEA. European Centre for Disease Prevention and Control, Stockholm, Sweden. https://www.ecdc.europa.eu/en/publications-data/systematic-review-hepatitis-b-and-c-prevalence-eueea.

4. Examining hepatitis c virus testing practices in primary care clinics

5. Hepatitis C Virus Antibody Positivity and Predictors Among Previously Undiagnosed Adult Primary Care Outpatients: Cross-Sectional Analysis of a Multisite Retrospective Cohort Study

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3